Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Managing Nausea in Post-Operative Patients with Constipation

Medication Selection

  • The National Comprehensive Cancer Network recommends prochlorperazine as a first-line agent for nausea management in patients who fail ondansetron, due to its effectiveness and lower side effect profile compared to promethazine 1, 2
  • Prochlorperazine is recommended over promethazine for nausea management in post-operative patients, as it causes less sedation and has fewer treatment failures 1, 2
  • The National Comprehensive Cancer Network suggests using promethazine for opioid-induced pruritus, but not as a primary agent for nausea management when alternatives are available 3

Management Algorithm

  • Ondansetron is recommended as a first-line treatment for nausea, but if it fails, prochlorperazine 10 mg PO/IV every 6 hours as needed is recommended 1, 2, 4
  • If prochlorperazine fails, consider adding a medication with a different mechanism of action, such as haloperidol 0.5-2 mg PO/IV every 4-6 hours 5
  • Metoclopramide 10-20 mg PO/IV every 6 hours may be considered for its prokinetic effects, which can help with both nausea and constipation 1, 3, 4
  • Dexamethasone 4-8 mg daily may be considered for persistent nausea 1, 5

Addressing Constipation

  • Assess for cause and severity of constipation and rule out bowel obstruction, and consider adding a stimulant laxative, such as bisacodyl 10-15 mg daily 3, 6
  • Osmotic laxatives, such as polyethylene glycol, lactulose, or magnesium citrate, may be considered to help with constipation 3, 4
  • The prokinetic effect of metoclopramide may help with both nausea and constipation 3, 4

Important Precautions

  • Monitor for extrapyramidal symptoms with prochlorperazine, and have diphenhydramine 25-50 mg available to treat potential extrapyramidal symptoms 5
  • Consider the patient's overall clinical picture, including other medications that may be contributing to constipation 6

REFERENCES

1

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

2

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

3

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

4

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

5

antiemesis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

6

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016